Xeris Biopharma Holdings, Inc. (XERS)
5.58
+0.15
(+2.76%)
USD |
NASDAQ |
Mar 19, 16:00
5.57
-0.01
(-0.18%)
After-Hours: 06:31
Xeris Biopharma Holdings Total Liabilities (Quarterly) : 379.25M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 190.22M |
| Zoetis, Inc. | 12.14B |
| Harrow, Inc. | 353.12M |
| Zymeworks, Inc. | 78.03M |
| Vir Biotechnology, Inc. | 259.65M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 392.94M |
| Shareholders Equity (Quarterly) | 13.69M |
| Debt to Equity Ratio | 18.85 |
| Current Ratio | 2.193 |
| Net Debt Paydown Yield | 0.20% |